BEAM
Baker Ellis Asset Management’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-3,000
| Closed | -$128K | – | 229 |
|
|
2019
Q3 | $128K | Hold |
3,000
| – | – | 0.03% | 205 |
|
|
2019
Q2 | $120K | Hold |
3,000
| – | – | 0.03% | 210 |
|
|
2019
Q1 | $125K | Hold |
3,000
| – | – | 0.03% | 194 |
|
|
2018
Q4 | $115K | Hold |
3,000
| – | – | 0.03% | 200 |
|
|
2018
Q3 | $121K | Sell |
3,000
-150
| -5% | -$6.05K | 0.03% | 220 |
|
|
2018
Q2 | $127K | Hold |
3,150
| – | – | 0.03% | 218 |
|
|
2018
Q1 | $123K | Hold |
3,150
| – | – | 0.03% | 222 |
|
|
2017
Q4 | $112K | Hold |
3,150
| – | – | 0.03% | 232 |
|
|
2017
Q3 | $128K | Hold |
3,150
| – | – | 0.03% | 220 |
|
|
2017
Q2 | $136K | Hold |
3,150
| – | – | 0.04% | 216 |
|
|
2017
Q1 | $133K | Sell |
3,150
-217
| -6% | -$9.16K | 0.04% | 220 |
|
|
2016
Q4 | $130K | Buy |
3,367
+367
| +12% | +$14.2K | 0.04% | 219 |
|
|
2016
Q3 | $129K | Hold |
3,000
| – | – | 0.04% | 220 |
|
|
2016
Q2 | $130K | Hold |
3,000
| – | – | 0.04% | 213 |
|
|
2016
Q1 | $122K | Hold |
3,000
| – | – | 0.04% | 220 |
|
|
2015
Q4 | $121K | Hold |
3,000
| – | – | 0.04% | 226 |
|
|
2015
Q3 | $115K | Hold |
3,000
| – | – | 0.04% | 229 |
|
|
2015
Q2 | $125K | Hold |
3,000
| – | – | 0.04% | 238 |
|
|
2015
Q1 | $138K | Hold |
3,000
| – | – | 0.04% | 232 |
|
|
2014
Q4 | $128K | Hold |
3,000
| – | – | 0.04% | 224 |
|
|
2014
Q3 | $138K | Hold |
3,000
| – | – | 0.05% | 226 |
|
|
2014
Q2 | $160K | Hold |
3,000
| – | – | 0.05% | 219 |
|
|
2014
Q1 | $160K | Hold |
3,000
| – | – | 0.06% | 224 |
|
|
2013
Q4 | $160K | Hold |
3,000
| – | – | 0.06% | 221 |
|
|
2013
Q3 | $151K | Hold |
3,000
| – | – | 0.06% | 219 |
|
|
2013
Q2 | $150K | Buy |
+3,000
| New | +$150K | 0.06% | 215 |
|